Chiron Announces Amended Merger Agreement with Novartis; Novartis to Acquire All Outstanding Chiron Shares for $48.00 Per Share
04 4월 2006 - 1:22AM
Business Wire
Chiron Corporation (Nasdaq:CHIR) today announced that it has
entered into an amendment to its previously announced merger
agreement with Novartis providing for Novartis to increase to
$48.00 per Chiron share the price it will pay for the approximately
56 percent of Chiron shares that Novartis does not already own. The
amended merger agreement has been unanimously approved by Chiron's
non-Novartis directors. The merger will now require a majority of
outstanding shares as of the record date to be voted in favor of
the transaction. Both CAM North America and ValueAct Capital have
informed Chiron and Novartis that they and their affiliated
entities intend to vote in favor of the transaction, subject to the
fiduciary and legal obligations applicable to them. Chiron today
also announced that it has reached an agreement in principle to
settle all claims in the previously reported stockholder actions
challenging the proposed transaction with Novartis. The proposed
settlement is subject to court approval following notice to the
class and a hearing. Chiron will promptly send updated proxy
materials to shareholders and plans to convene the special
shareholders meeting as scheduled on April 12, 2006, and to
immediately adjourn the meeting and then reconvene on April 19,
2006. As all necessary regulatory approvals were previously
received, Chiron expects the merger to close promptly after the
stockholder vote on April 19, 2006. About Chiron Chiron delivers
innovative and valuable products to protect human health by
advancing pioneering science across the landscape of biotechnology.
The company works to deliver on the limitless promise of science
and make a positive difference in people's lives. For more
information about Chiron, please visit www.chiron.com.
Chiron (NASDAQ:CHIR)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 9월(9) 2024
Chiron (NASDAQ:CHIR)
과거 데이터 주식 차트
부터 9월(9) 2023 으로 9월(9) 2024